The Patent Finder

Terms ending in 2042

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,109,310Exosome Extracellular Vesicles and Methods of Use
AstraZeneca AB and Valadi, Hadi
In force
 · High confidence
AstraZeneca AB and Valadi, HadiIn forceHigh confidence
US 12,668,785Combination Treatment by Administering a Recombinant Apyrase Protein in Conjunction with a P2Y12 Inhibitor
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,651,863Predicting Prostate Cancer Recurrence Using a Prognostic Model that Combines Immunohistochemical Staining and Gene Expression Profiling
In force
 · High confidence
AstraZeneca Computational Pathology GmbHIn forceHigh confidence
US 11,798,653Methods for Determining Treatment for Cancer Patients
In force
 · High confidence
MedImmune, LLCIn forceHigh confidence
US 11,845,791Antibodies Directed Against GDF-15
In force
 · High confidence
MedImmune, LLCIn forceHigh confidence
US 11,883,582Inhaler
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,060,429Method of Treating Type 1 Interferon (IFN)-Mediated Disease Using a Subcutaneous Dosing Regimen Comprising Anifrolumab
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 12,620,146Graph Construction and Visualization of Multiplex Immunofluorescence Images
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,365,678Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b] pyridine and intermediates
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 11,970,463Compounds and Their Use
In force
 · High confidence
Tanabe Pharma CorporationIn forceHigh confidence
12 more term ends in 2042 · Pro
10 of 22 patents shown. Soonest term end first, then patent number.
Pro members see all 22.
Upgrade to Pro
16 of these are in force and held by AstraZeneca AB.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited